A STATISTICAL MODEL TO STUDY COST-EFFECTIVENESS OF ANTIVIRAL TREATMENT IN HCV RECURRENCE AFTER LIVER TRANSPLANTATION

被引:0
|
作者
Logge, Christoph [1 ]
Vettorazzi, Eik [2 ]
Fischer, Lutz [1 ]
Nashan, Bjoern [1 ]
Sterneck, Martina [1 ]
机构
[1] Med Univ Ctr Hamburg Eppendorf, Dept Hepatobiliary & Transplant Surg, Hamburg, Germany
[2] Med Univ Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
519
引用
收藏
页码:553A / 553A
页数:1
相关论文
共 50 条
  • [31] HLA Implication in HCV Recurrence after Liver Transplantation
    Lupo, Luigi
    Panzera, Piercarmine
    Cesana, Andrea
    Notarnicola, Rosamaria
    De Blasi, Vito
    Memeo, Vincenzo
    LIVER TRANSPLANTATION, 2010, 16 (06) : S228 - S228
  • [32] Natural α-IFN in HCV recurrence after liver transplantation
    Targhetta, S
    Burra, P
    Popovic, A
    Silverj, E
    Pevere, S
    Russo, FP
    Zanus, G
    Cecchetto, A
    Naccarato, R
    Fagiuoli, S
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1457 - 1458
  • [33] ANTIVIRAL TREATMENT (AT) FOR HCV RECURRENCE FOLLOWING LIVER TRANSPLANTATION (LT): IMPACT ON LIVER HISTOLOGY IN NON RESPONDERS, AN ITALIAN MULTICENTER RETROSPECTIVE STUDY
    De Martin, Eleonora
    TRANSPLANT INTERNATIONAL, 2010, 23 : 19 - 19
  • [34] Immunogenetic factors, HCV genotypes, and HCV recurrence after liver transplantation
    Belli, LS
    Zavaglia, C
    Alberti, AB
    Rondinara, GF
    De Carlis, L
    Silini, E
    Poli, F
    Scalamogna, M
    Tinelli, G
    Forti, D
    Ideo, G
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 483 - 484
  • [35] SUSTAINED VIROLOGIC RESPONSE IN THE ANTIVIRAL TREATMENT OF HCV-INFECTION AFTER LIVER TRANSPLANTATION
    Yaroshenko, Ekaterina
    Kornilov, Maxim
    Moysyuk, Yan
    TRANSPLANT INTERNATIONAL, 2013, 26 : 291 - 291
  • [36] Influence of steroids on HCV recurrence after liver transplantation: A prospective study.
    Vivarelli, Marco
    Burra, Patrizia
    La Barba, Giuliano
    Canova, Daniele
    Cucchetti, Alessandro
    Senzolo, Marco
    Guido, Maria
    D'Errico, Antonia
    Merenda, Roberto
    Neri, Daniele
    Cillo, Umberto
    Pinna, Antonio D.
    LIVER TRANSPLANTATION, 2007, 13 (06) : S158 - S158
  • [37] Fibrosis progression on protocol liver biopsies in patients with or without antiviral treatment for HCV recurrence following liver transplantation (LT)
    De Martin, Eleonora
    Boninsegna, Sara
    Senzolo, Marco
    Guido, Maria
    Russo, Francesco P.
    Germani, Giacomo
    Gambato, Martina
    Masier, Annalisa
    Zanus, Giacomo
    Burra, Patrizia
    TRANSPLANT INTERNATIONAL, 2008, 21 : 6 - 6
  • [38] Fibrosis Progression in Non Responders to Antiviral Treatment (AT) in HCV Recurrence Following Liver Transplantation (LT): An Italian Multicenter Retrospective Study
    De Martin, Eleonora
    Senzolo, Marco
    Francesca, Ponziani R.
    Pasulo, Luisa
    Vigano, Raffaella
    Belli, Luca
    Donato, Francesca
    Angelico, Mario
    Di Paolo, Daniele
    Rendina, Maria
    Miglioresi, Lucia
    Grazi, Gian Luca
    Morelli, Mariacristina
    Toniutto, Pierluigi
    Merli, Manuela
    Giannelli, Valerio
    Castellaneta, Nicola M.
    Marino, Maria
    Iemmolo, Rosa M.
    Gerunda, Giorgio E.
    Villa, Erica
    Gasbarrini, Antonio
    Fagiuoli, Stefano
    Burra, Patrizia
    LIVER TRANSPLANTATION, 2010, 16 (06) : S130 - S130
  • [39] The Cost-Effectiveness of Sofosbuvir Treatment Pre-Transplant to Prevent HCV Recurrence Post-Transplant
    Agarwal, Kosh
    Gane, Ed
    Forns, Xavier
    Manns, Michael
    Saab, Sammy
    Colombo, Massimo
    Younossi, Zobair
    Terrault, Norah
    McHutchison, John
    LIVER TRANSPLANTATION, 2014, 20 : S148 - S148
  • [40] COST-EFFECTIVENESS OF LIVER TRANSPLANTATION IN METHYLMALONIC AND PROPIONIC ACIDEMIAS
    Li, M.
    Veenstra, D. L.
    Dick, A. A.
    Montenovo, M., I
    Horslen, S. P.
    Hansen, R. N.
    VALUE IN HEALTH, 2014, 17 (03) : A229 - A229